European Neuropsychopharmacology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus.
28:307-316.
2018
-
Epigenetic induction of melatonin MT 1 receptors by valproate: Neurotherapeutic implications.
27:828-832.
2017
-
New treatment models for compulsive disorders.
26:877-884.
2016
-
The cost and impact of compulsivity: A research perspective.
26:800-809.
2016
-
No effect of oral l-tryptophan or alpha-lactalbumin on total tryptophan levels in breast milk.
25:779-787.
2015
-
Verbal episodic memory along the course of schizophrenia and bipolar disorder: A new perspective.
25:169-175.
2015
-
The influence of age at onset and duration of illness on long-term outcome in patients with obsessive-compulsive disorder: A report from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS).
23:865-871.
2013
-
PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia.
23:253-262.
2013
-
Illness duration and total brain gray matter in bipolar disorder: Evidence for neurodegeneration?.
18:717-722.
2008
-
Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study.
12:269-272.
2002
-
Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia.
10:389-395.
2000
-
Lisdexamfetamine dimesylate in adult ADHD with anxiety disorder and depression comorbidity: A 17-week cross-over study
2019
-
HOARDING IN USERS OF ONLINE CLASSIFIED ADVERTSEMENTS
2018
-
ASSOCIATION AND PREDICTIVE VALUE OF GENETIC RISK SCORE FOR SCHIZOPHRENIA AND COGNITIVE PROFILES IN UNAFFECTED SIBLINGS: THE GROUP STUDY
2017
-
Clinical correlates of early-onset bipolar I disorder
2017
-
DIFFERENTIAL EXPRESSION OF TRANSCRIPTION FACTORS IN THE PREFRONTAL CORTEX OF INDIVIDUALS WITH BIPOLAR DISORDER
2017
-
GENOME-WIDE ASSOCIATION STUDY IN DULOXETINE AND PLACEBO RESPONSE
2017
-
GENOME-WIDE DE NOVO MUTATION LANDSCAPE IN AUTISM SPECTRUM DISORDER
2017
-
GWAS-BASED MACHINE LEARNING APPROACH TO PREDICT DULOXETINE RESPONSE IN MAJOR DEPRESSIVE DISORDER
2017
-
Pokemon Go: is it a potential tool for mental health?
2017
-
Predicting functional impairment in bipolar disorder: a pilot study with a machine learning approach
2017
-
Prevalence of anxiety and depressive symptoms in a Canadian medical cannabis use cohort
2017
-
THINKING AND DOING: THE EFFECTS OF DOPAMINE AND OXYTOCIN GENES AND EXECUTIVE FUNCTION ON MOTHERING BEHAVIOURS
2017
-
CHILDHOOD, ADOLESCENT AND ADULT AGE AT ONSET AND RELATED CLINICAL CORRELATES IN OBSESSIVE-COMPULSIVE DISORDER: A REPORT FROM THE INTERNATIONAL COLLEGE OF OBSESSIVE-COMPULSIVE DISORDERS (ICOCS)
2017
-
NEUROIMAGING OF SUBCORTICAL BRAIN VOLUME ALTERATIONS IN PEADIATRIC AND ADULT OBSESSIVE-COMPULSIVE DISORDER: Preliminary findings from the ENIGMA Obsessive-Compulsive Disorder working group
2017
-
Hoarding in users of online classified advertisements
2016
-
Improved resilience against depressed mood in early postpartum after dietary supplement administration
2016
-
Internet addiction or psychopathology in disguise? Results from a survey of college-aged internet users
2016
-
Prediction of early-onset eating disorders and obesity: the role of neuropsychological performance at age 4
2016
-
P.1.c.015 Cognitive development in 4-to 6-year old children: does the Cambridge neuropsychological test automated battery provide a reliable assessment?
2015
-
P.2.b.017 Structural brain alterations in major depression: findings from the ENIGMA Major Depressive Disorder Working Group
2015
-
P.2.c.008 Cell therapy as a strategy for the treatment of bipolar disorder: preliminary results of a study using an animal model of mania
2015
-
P.2.d.015 Short telomeres in subjects with remitted bipolar disorder
2015
-
P.2.h.003 Reduction in depressed mood after dietary supplementation during postpartum blues
2015
-
P.4.d.004 The influence of baseline severity on antidepressant efficacy for anxiety disorders: a meta-analysis and meta-regression
2015
-
P.6.e.002 Problematic internet use in the general population: results from an internet-based survey
2015
-
S.20.04 Gut-brain communication: how the microbiome influences anxiety and depression
2015
-
P.1.i.034 The impact of 5-HTTLPR and BDNF Val66Met on heterogeneity of intrinsic connectivity of amygdala in major depressive disorder
2014
-
P.2.c.004 The receptor P2X7 participates in the amphetamine-induced increase of a proinflammatory environment in an animal model of mania
2014
-
P.2.c.005 Use of mesenchymal stem cells as a novel treatment for bipolar disorder: preliminary results of an in vitro study
2014
-
P.2.c.009 Epigenetically-induced modulation of the stress axis associated with the progression of bipolar disorder
2014
-
P.2.d.033 Staging bipolar disorder: biological, clinical and functional correlates
2014
-
P.2.d.054 A pilot, open-label, 8-week study evaluating the efficacy of adjunctive minocycline for the treatment of bipolar I/II depression
2014
-
P.3.d.064 Antipsychotic re-challenge in previous responders
2014
-
P.4.a.007 Internet use for social communication in adolescents with social anxiety disorder
2014
-
P.4.c.001 The use of augmentation strategies in treatment resistant anxiety disorders: a meta-analysis and systematic review
2014
-
Evaluation of peripheral biomarkers in bipolar and unipolar depression
2013
-
P.1.g.067 Tianeptine has neuroprotective effects in a differentiated SH-SY5Y human neuroblastoma cell line
2013
-
P.1.g.078 Approaches to create dietary supplements to prevent postpartum depression
2013
-
P.2.d.009 The predictive role of Val66Met polymorphism on levels of BDNF along treatment of medication-free patients with bipolar disorder
2013
-
P.2.d.046 C-reactive protein is elevated in bipolar disorder
2013
-
P.3.b.034 Insight, treatment outcomes and recovery in first-episode schizophrenia
2013
-
P.4.e.007 Perceptions of obsessive compulsive disorder and the impact on treatment outcomes
2013
-
P.4.e.008 The use of technology-based communication and the impact on the social functioning of individuals with and without social phobia
2013
-
P.2.e.027 Interleukin-6 as a biomarker of the model of staging in bipolar disorder
2012
-
P.4.a.010 Adult attention deficit hyperactivity disorder and anxiety disorder comorbidity: prevalence in a clinical sample
2012
-
P.4.e.007 Internet screening for anxiety disorders and effects on treatment-seeking three months later
2012
-
P.4.f.003 Recent life stress in pregnant immigrant women and its association with HPA axis activity
2012
-
S.06.04 Staging and biomarkers in bipolar disorders
2012
-
Brain-derived neurotrophic factor as a biomarker of clinical response in bipolar disorder: 16-week follow-up study
2012
-
E.01.01 Overview
2011
-
P.2.e.001 Methylene blue for residual symptoms and for cognitive dysfunction in bipolar disorder: results of a double-blind trial
2011
-
P.4.b.005 Panic attacks and generalised anxiety disorder
2011
-
P.4.b.019 Panic attacks associated with generalised anxiety disorder
2010
-
S.22.02 Alostatic load and oxidative stress in bipolar disorder
2010
-
P.2.a.049 Functional outcome after 12 months of deep brain stimulation for treatment resistant major depressive disorder
2009
-
P.4.a.006 Internet-based screening of anxiety disorders
2009
-
P.4.f.001 The impact of changing diagnostic criteria in posttraumatic stress disorder (PTSD)
2009
-
P.2.a.010 The depression inventory development workgroup: results from the second validation study
2008
-
P.4.e.006 Perinatal Obsessive-Compulsive Scale (POCS): preliminary data
2008
-
P.4.f.003 Effect of stress on brain activation patterns in women with postpartum obsessive-compulsive and depressive disorders
2008
-
P.8.a.034 The composite international diagnostic interview-for women (CIDI-VENUS): a pilot study
2008
-
P.8.b.002 Early maternal experience, maternal sensitivity, infant emotion regulation and HPA function
2008
-
S.06.03 Phenotyping OCD: new insights from animal behaviour
2008
-
S.15.03 Early experiences affect brain and behaviour: a comparison of rat and human mothers
2008
-
S.15.05 The risk:benefit ratio of using antidepressants during pregnancy
2008
-
P.4.a.008 A randomized placebo controlled trial of olanzapine in trichotillomania
2006
-
S.15.02 Dopamine model of OCD in rats
2006
-
A pilot study of topiramate augmentation in treatment resistant obsessive-compulsive disorder
2005
-
Tiagabine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study
2005
-
P.1.035 An open study of instant dose citalopram inpremenstrual dysphoric disorder
2004
-
P.3.008 Treatment of trichotillomania with atypicalantipsychotics: A case series
2004
-
P.1.190 Prevalence and management of depression with painful physical symptoms in a Canadian claims database
2003
-
P.2.131 Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia
2003
-
P.3.048 Generalized anxiety disorder (GAD): Gender differences in clinical presentation and response to sertraline
2003
-
S.14.05 Long-term efficacy and safety of atypical and conventional antipsychotic drugs in first episode schizophrenia
2003
-
Cardiac conduction in females and males under intramuscular (IM) and oral olanzapine from schizophrenia clinical trials ECGs
2002
-
Mood disorders and sexual dimorphism in neurotransmitter systems
2002
-
Predictors of remission in patients treated with sertraline for moderate to severe generalized social phobia
2002
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)